×
Hero Background

Conjugate Vaccine Companies

ID: MRFR/Pharma/2981-HCR
115 Pages
Rahul Gotadki
October 2025

Conjugate vaccines are a type of vaccine that consists of a combination of a bacterial or viral antigen and a carrier protein. These vaccines are designed to enhance the immune response, particularly in young children whose immune systems may not respond well to certain pathogens. Several pharmaceutical and biotechnology companies are engaged in the development and production of conjugate vaccines.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Conjugate Vaccines Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Conjugate Vaccine Market

Conjugate vaccines Market

 


Latest Conjugate Vaccine Companies Updates:


Pfizer Announced a partnership with the Bill & Melinda Gates Foundation to develop and distribute a new conjugate vaccine for Group A Streptococcus (GAS) infections.


Merck & Co Launched their Gardasil 9 (human papillomavirus vaccine) in a single-dose format, aiming to improve vaccination rates among adolescents.


Serum Institute of India Expanded their manufacturing capacity for conjugate vaccines, solidifying their position as a major vaccine supplier in developing countries.


List of Conjugate Vaccine Key companies in the market:



  • GlaxoSmithKline plc.

  • Merck & Co., Inc. in the U.S

  • Fab life.in India

  • SutroVax Inc. In the U.S

  • Sanofi Pasteur SA. In France

  • Pfizer in the U.S

  • Sinovac Biotech Ltd. in China

  • IDT Biologics GmbH

  • GreenSignal Bio Pharma Limited in India

  • Taj Pharmaceuticals Limited in India

  • Bavarian Nordic in U.S